Boyd Watterson Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3,710
Closed -$624K 142
2018
Q1
$624K Buy
3,710
+1,264
+52% +$212K 0.31% 85
2017
Q4
$400K Sell
2,446
-1,494
-38% -$268K 0.19% 108
2017
Q3
$808K Buy
3,940
+32
+0.8% +$7.44K 0.4% 71
2017
Q2
$950K Buy
3,908
+197
+5% +$46.3K 0.49% 54
2017
Q1
$887K Buy
3,711
+354
+11% +$82.4K 0.44% 70
2016
Q4
$705K Buy
3,357
+24
+0.7% +$4.97K 0.37% 80
2016
Q3
$768K Buy
3,333
+7
+0.2% +$1.71K 0.38% 76
2016
Q2
$769K Buy
+3,326
New +$767K 0.37% 77

Other funds holding AGN

Boyd Watterson Asset Management's AGN Position: Q2 2018 in Review

Boyd Watterson Asset Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 3,710 shares — an estimated $624K sold.

Boyd Watterson Asset Management first reported a position in AGN in Q2 2016 and held it in 8 quarters. The position peaked at $950K in Q2 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Boyd Watterson Asset Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Boyd Watterson Asset Management sold 3,710 Allergan plc shares in Q2 2018, an estimated $624K.
  • Boyd Watterson Asset Management first reported a position in Allergan plc in Q2 2016 and held it in 8 quarters.
  • Boyd Watterson Asset Management's Allergan plc position peaked at $950K in Q2 2017.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Boyd Watterson Asset Management's 13F filing for Q2 2018, filed 18 Jul 2018.